{"id":"https://openalex.org/W4244471199","doi":"https://doi.org/10.1002/14651858.cd003026.pub2","title":"Treatment for amphetamine psychosis","display_name":"Treatment for amphetamine psychosis","alternate_titles":[],"publication_year":2008,"publication_date":"2008-10-08","ids":{"openalex":"https://openalex.org/W4244471199","doi":"https://doi.org/10.1002/14651858.cd003026.pub2","pmid":"https://pubmed.ncbi.nlm.nih.gov/18843639"},"language":"en","primary_location":{"id":"doi:10.1002/14651858.cd003026.pub2","doi":"https://doi.org/10.1002/14651858.cd003026.pub2","is_oa":false,"landing_page_url":"https://doi.org/10.1002/14651858.cd003026.pub2","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Cochrane Database of Systematic Reviews (Complete Reviews)","raw_type":"reference-entry"},"parent_works":[],"lineage":["https://openalex.org/W4244471199"],"child_works_count":0,"type":"reference-entry","is_traditional":false,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059600880","display_name":"STEVEN J. SHOPTAW","orcid":"https://orcid.org/0000-0002-3583-0026","observed_orcids":["https://orcid.org/0000-0002-3583-0026"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2803209242","display_name":"University of California System","ror":"https://ror.org/00pjdza24","country_code":"US","type":"education","lineage":["https://openalex.org/I2803209242"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven J Shoptaw","raw_affiliation_strings":["Family Medicine, University of California, 10880 Wilshire Blvd Suite 540, Los Angeles, California 90024, USA. sshoptaw@mednet.ucla.edu","University of California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Family Medicine, University of California, 10880 Wilshire Blvd Suite 540, Los Angeles, California 90024, USA. sshoptaw@mednet.ucla.edu","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"University of California","institution_ids":["https://openalex.org/I2803209242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025577892","display_name":"Uyen H. Kao","orcid":"https://orcid.org/0000-0002-7463-9953","observed_orcids":["https://orcid.org/0000-0002-7463-9953"]},"institutions":[{"id":"https://openalex.org/I2803209242","display_name":"University of California System","ror":"https://ror.org/00pjdza24","country_code":"US","type":"education","lineage":["https://openalex.org/I2803209242"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Uyen Kao","raw_affiliation_strings":["University of California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California","institution_ids":["https://openalex.org/I2803209242"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049281885","display_name":"Walter W Ling","orcid":"https://orcid.org/0000-0003-0664-5099","observed_orcids":["https://orcid.org/0000-0003-0664-5099"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Walter W Ling","raw_affiliation_strings":["David Geffen School of Medicine at UCLA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at UCLA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":33,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"4","first_page":"CD003026","last_page":"CD003026"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.031300000846385956,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amphetamine-induced-psychosis","display_name":"amphetamine psychosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7580000162124634},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":1.0},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonists","display_name":"dopamine antagonists","score":0.8690000176429749},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9120000004768372},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6520000100135803},{"id":"https://openalex.org/keywords/paranoia","display_name":"paranoia","score":0.37700000405311584},{"id":"https://openalex.org/keywords/hallucinations","display_name":"hallucinations","score":0.9789999723434448},{"id":"https://openalex.org/keywords/agitation","display_name":"agitation","score":0.40799999237060547},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.5559999942779541},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.3799999952316284},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.32199999690055847}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8609253168106079},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7222295999526978},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.6771281957626343},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6478291153907776},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.6437987089157104},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.6297877430915833},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.5884926319122314},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5576968789100647},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.5510936379432678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5448728203773499},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.5400190949440002},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.45643627643585205},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4499555230140686},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4234920144081116},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.35766851902008057},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.32576245069503784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25999587774276733},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.1932443082332611},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.1179475486278534}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011605","descriptor_name":"Psychoses, Substance-Induced","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019969","descriptor_name":"Amphetamine-Related Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/14651858.cd003026.pub2","doi":"https://doi.org/10.1002/14651858.cd003026.pub2","is_oa":false,"landing_page_url":"https://doi.org/10.1002/14651858.cd003026.pub2","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Cochrane Database of Systematic Reviews (Complete Reviews)","raw_type":"reference-entry"},{"id":"pmid:18843639","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18843639","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Cochrane database of systematic reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W173735914","https://openalex.org/W1572815584","https://openalex.org/W1899525761","https://openalex.org/W1928309148","https://openalex.org/W1963672536","https://openalex.org/W1983314012","https://openalex.org/W1984582808","https://openalex.org/W1984869085","https://openalex.org/W1986489757","https://openalex.org/W1988937453","https://openalex.org/W1989218594","https://openalex.org/W2001607741","https://openalex.org/W2010015246","https://openalex.org/W2011932878","https://openalex.org/W2015909694","https://openalex.org/W2016291488","https://openalex.org/W2016383988","https://openalex.org/W2049986482","https://openalex.org/W2056425055","https://openalex.org/W2058492141","https://openalex.org/W2060828811","https://openalex.org/W2061717381","https://openalex.org/W2073023197","https://openalex.org/W2075165192","https://openalex.org/W2084124132","https://openalex.org/W2087723693","https://openalex.org/W2100321683","https://openalex.org/W2102695827","https://openalex.org/W2109481947","https://openalex.org/W2112015708","https://openalex.org/W2117051140","https://openalex.org/W2139155586","https://openalex.org/W2143955872","https://openalex.org/W2155879003","https://openalex.org/W2163320407","https://openalex.org/W4213320681"],"related_works":["https://openalex.org/W173735914","https://openalex.org/W4408590900","https://openalex.org/W2980832584","https://openalex.org/W7220955995","https://openalex.org/W4294202925","https://openalex.org/W2049059629","https://openalex.org/W4237352649","https://openalex.org/W2792815229","https://openalex.org/W2088092711","https://openalex.org/W2510195332"],"abstract_inverted_index":{"BACKGROUND:":[0],"Chronic":[1],"amphetamine":[2,31,42,82,162,254,271,339,363,394],"users":[3],"may":[4,322],"have":[5],"experience":[6],"of":[7,30,39,61,159,181,243,251,270,311,362,369,376,385,393],"paranoia":[8],"and":[9,23,69,91,175,179,189,211,231,241,276,290,318,357,366],"hallucination.":[10],"It":[11],"has":[12,256],"long":[13],"been":[14,257],"believed":[15],"that":[16,208,264,299,316,347],"dopamine":[17],"antagonists,":[18],"such":[19],"as":[20,110,197,237],"chlorpromazine,":[21],"haloperidol,":[22],"thioridazine,":[24],"are":[25,295,352,378],"effective":[26],"for":[27,41,79,161,167,253,306,338,381,389],"the":[28,93,106,113,121,131,146,165,177,224,234,273,287,303,367,374,383],"treatment":[29,160,252,391],"psychosis.":[32,43,204,395],"OBJECTIVES:":[33],"To":[34],"evaluate":[35],"risks,":[36],"benefits,":[37],"costs":[38],"treatments":[40,75],"SEARCH":[44],"STRATEGY:":[45],"MEDLINE":[46],"(1966-2007),":[47],"EMBASE":[48],"(1980-2007),":[49],"CINAHL":[50],"(1982-2007),":[51],"PsychINFO":[52],"(1806-2007),":[53],"CENTRAL":[54],"(Cochrane":[55],"Library":[56],"2008":[57],"issue":[58],"1),":[59],"references":[60],"obtained":[62],"articles.":[63],"SELECTION":[64],"CRITERIA:":[65],"All":[66],"randomised":[67,156],"controlled":[68,157],"clinical":[70],"trials":[71],"(RCTs,":[72],"CCTs)":[73],"evaluating":[74],"(alone":[76],"or":[77],"combined)":[78],"people":[80],"with":[81,112,120,139,223],"psychosis":[83,163,255,372],"DATA":[84],"COLLECTION":[85],"AND":[86],"ANALYSIS:":[87],"Two":[88],"authors":[89],"evaluated":[90],"extracted":[92,99],"data":[94,97],"independently.":[95],"Dichotomous":[96],"were":[98,108,217],"on":[100],"an":[101,326],"intention-to-treat":[102],"basis":[103],"in":[104,201,219,373],"which":[105],"dropouts":[107],"assigned":[109],"participants":[111,174],"worst":[114],"outcomes.":[115],"The":[116,134,151,170,205,309],"Relative":[117],"Risk":[118],"(RR)":[119],"95%":[122,140],"confidence":[123],"interval":[124],"(95%":[125],"CI)":[126],"was":[127,142],"used":[128,143,193,196,292],"to":[129,144,371],"assess":[130,145],"dichotomous":[132],"data.":[133,148],"Weighted":[135],"Mean":[136],"Difference":[137],"(WMD)":[138],"CI":[141],"continuous":[147],"MAIN":[149],"RESULTS:":[150],"comprehensive":[152],"searches":[153],"found":[154],"one":[155,249],"trial":[158,262],"meeting":[164],"criteria":[166,305],"considering":[168],"studies.":[169],"study":[171,386],"involved":[172],"58":[173],"compared":[176],"efficacy":[178],"tolerability":[180,232,285],"two":[182,297,313],"antipsychotic":[183,194,265,279,329],"drugs,":[184],"olanzapine":[185,210,225],"(a":[186,191],"newer":[187,274,355],"antipsychotic)":[188],"haloperidol":[190,212,235],"commonly":[192,291],"medication":[195],"a":[198],"control":[199,236],"condition),":[200],"treating":[202],"amphetamine-induced":[203],"results":[206,310],"show":[207,315],"both":[209],"at":[213],"clinically":[214],"relevant":[215],"doses":[216],"efficacious":[218],"resolving":[220],"psychotic":[221,320,340,364],"symptoms,":[222],"condition":[226],"showing":[227],"significantly":[228,283],"greater":[229],"safety":[230],"than":[233,286],"measured":[238],"by":[239],"frequency":[240],"severity":[242],"extrapyramidal":[244],"symptoms.":[245],"AUTHORS'":[246],"CONCLUSIONS:":[247],"Only":[248],"RCT":[250],"published.":[258],"Outcomes":[259],"from":[260],"this":[261,307,332],"indicate":[263],"medications":[266,346],"effectively":[267],"reduce":[268],"symptoms":[269,321,365],"psychosis,":[272],"generation":[275],"more":[277,288],"expensive":[278],"medication,":[280,293],"olanzapine,":[281],"demonstrates":[282],"better":[284],"affordable":[289],"haloperidol.There":[294],"other":[296],"studies":[298,314,361,392],"did":[300],"not":[301,343],"meet":[302],"inclusion":[304],"review.":[308],"these":[312],"agitation":[317],"some":[319],"be":[323,336,349],"abated":[324],"within":[325],"hour":[327],"after":[328],"injection.":[330],"Whether":[331],"limited":[333],"evidence":[334],"can":[335],"applied":[337],"patients":[341],"is":[342],"yet":[344],"known.The":[345],"should":[348],"further":[350,390],"investigate":[351],"conventional":[353],"antipsychotics,":[354],"antipsychotics":[356],"benzodiazepines.":[358],"However,":[359],"naturalistic":[360],"prevalence":[368],"relapse":[370],"presence":[375],"amphetamine,":[377],"also":[379],"crucial":[380],"advising":[382],"development":[384],"designs":[387],"appropriate":[388]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4244471199","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2022-05-12T00:00:00"}
